mapping the effectiveness and risks of glp-1 receptor agonists pdf Exploring the Side Effects of

Weekly injections, ongoing monitoring, and the need to manage side effects can become burdensome over time

Cardiovascular and kidney benefits of SGLT-2is and GLP-1RAs according to baseline blood pressure in type 2 diabetes: a systematic meta-analysis of cardiovascular outcome trials

It is worth noting that this cardioprotective effect of exenatide outweighed the fact that a greater proportion of patients on exenatide treatment possessed CVD risk factors such as prior ischemic heart disease, obesity, hyperlipidemia, and hypertension [98]

Accordingly, an initial drop in eGFR occurred in patients treated with both once-weekly and oral semaglutide in a post-hoc analysis of pooled data from SUSTAIN-6 and PIONEER 6, followed by a slower eGFR decline vs

Blundell J, Finlayson G, Axelsen M, et al